VISEN Pharmaceuticals (02561)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Cao Yibo | 08-Jan-21 | Non-Executive Director | |||
| Jensen Michael Wolff | 08-Jan-21 | Ch | |||
| Michael Wolff Jensen | 27-Jun-25 | Non-Executive Director | Retired from the office at the conclusion of the AGM to strengthen the independence of the Board and ultimately the governance of the Company. | ||
| Jan MøLler Mikkelsen | 27-Jun-25 | Non-Executive Director | Retired from the office at the conclusion of the AGM to strengthen the independence of the Board and ultimately the governance of the Company. | ||
| Ni Hope Hong | 01-Apr-21 | 26-Mar-24 | INED | ||
| Dong Dandan | 07-Nov-18 | 13-Dec-23 | ED | ||
| Chang Michael J | 01-Dec-23 | 16-Sep-22 | Non-Executive Director | ||
| Mikkelsen Jan MøLler | 07-Nov-18 | 31-Dec-21 | Non-Executive Director | ||
| Yao Zhengbin | 01-Apr-21 | 31-Dec-21 | INED | ||
| Chan Sze Ting | 08-Mar-25 | 16-Dec-20 | CoSec | ||
| Lu Anbang | 07-Nov-18 | 20-Dec-19 | CEO | ||
| Jensen Michael Wolff | 08-Jan-21 | 29-Dec-16 | Non-Executive Director | ||
| Fu Shan | 01-Nov-18 | 04-Nov-16 | Non-Executive Director | ||
| Chan Peng Kuan | 01-Apr-21 | 01-Jan-15 | INED |